ANI Pharmaceuticals | ANIP - Equity Capital And Reserves


ANI Pharmaceuticals reported $562.3M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
AbbVie USD -6.66B 3.39B Mar/2026
ANI Pharmaceuticals USD 562.3M 21.58M Mar/2026
Assertio Holdings USD 105.8M 12.5M Sep/2025
Aurora Cannabis CAD 536.36M 30.74M Dec/2025
Canopy Growth CAD 758.17M 22.16M Dec/2025
Eli Lilly USD 31.2B 4.66B Mar/2026
Emergent BioSolutions USD 649.3M 47.9M Dec/2023
Heron Therapeutics USD 9.14M 4.15M Mar/2026
Hikma Pharmaceutical USD 2.59B 42M Dec/2025
Knight Therapeutics CAD 767.27M 480K Dec/2025
Nektar Therapeutics USD 89.83M 4.75M Dec/2025
Novartis USD 46.13B 1.8B Dec/2025
Omeros USD -228.68M 15.13M Jun/2025
Perrigo USD 2.5B 436.7M Mar/2026
Sun Pharmaceuticals INR 835.7B 57.5B Mar/2026
Teva Pharmaceutical Industries USD 8.23B 314M Mar/2026